Full Text View
Tabular View
No Study Results Posted
Related Studies
ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure
This study has been terminated.
Study NCT00283361   Information provided by Zealand Pharma
First Received: January 25, 2006   Last Updated: February 27, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure, Congestive
Additional conditions recognized in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
ZP120
I.v. catherization
6-minutes walk performance
Dyspnea severity assessment
Blood sampling for laboratory tests
ECG
Physical examination
Additional drug interventions recognized in this trial
Furosemide
More general drug interventions related to this trial
Cardiovascular Agents
Diuretics
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Zealand Pharma
Kendle International


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services